RecruitingNCT06947941
This study exists to explore whether this type of care could improve care and understanding. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.
SchizophreniaOtherFrom 55 Years to 90 Years
- Countries
- Australia, Canada, Japan, United Kingdom, United States
- Sponsor
- Bristol-Myers Squibb
- Condition
- Schizophrenia
TerminatedNCT05211947
This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 51 Years
- Countries
- Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Italy, Japan, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, Philippines, Poland, Portugal, Romania, Serbia, Slovakia, South Korea, Spain, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, United States
- Sponsor
- Boehringer Ingelheim
- Condition
- Schizophrenia
CompletedNCT04860830
This study exists to learn from real-world information that can show how questionnaires and follow-up reports fits into care. Researchers are trying to understand whether questionnaires and follow-up reports can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- Argentina, Austria, Belgium, Brazil, Bulgaria, China, Czech Republic, Denmark, Finland, Germany, Lithuania, Mexico, Portugal, Serbia, South Korea, Taiwan, United Kingdom, United States
- Sponsor
- Boehringer Ingelheim
- Condition
- Schizophrenia
CompletedNCT06315283
This study exists to see whether the medication TV-44749 can play a useful role in care. Researchers are trying to understand how people respond to the medication TV-44749 in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 64 Years
- Countries
- Croatia, Spain, United Kingdom, United States
- Sponsor
- Teva Branded Pharmaceutical Products R&D LLC
- Condition
- Schizophrenia
CompletedNCT05480046
This study exists to understand whether the medication Risperidone is both safe enough and useful enough to take further. Researchers are trying to understand whether the medication Risperidone can better prevent setbacks and support longer-term stability.
SchizophreniaOtherOver 18 Years
- Countries
- Germany, Italy, Portugal, Spain, United Kingdom
- Sponsor
- Rovi Pharmaceuticals Laboratories
- Condition
- Schizophrenia
CompletedNCT03677635
This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United Kingdom
- Sponsor
- King's College London
- Condition
- Schizophrenia
TerminatedNCT03230097
This study exists to learn from real-world information that can show how questionnaires and follow-up reports fits into care. Researchers are trying to understand what questionnaires and follow-up reports could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 16 Years to 30 Years
- Countries
- Canada, China, United Kingdom, United States
- Sponsor
- Boehringer Ingelheim
- Condition
- Schizophrenia
CompletedNCT00460512
This study exists to understand whether the medication Flexibly is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to the medication Flexibly in practice and what may need to be adjusted.
SchizophreniaOtherOver 18 Years
- Countries
- Belgium, Bulgaria, Croatia, Denmark, Finland, France, Germany, Greece, Hungary, Israel, Latvia, Lithuania, Netherlands, Poland, Portugal, Russian Federation, Serbia, Spain, Sweden, Switzerland, Turkey, United Kingdom
- Sponsor
- Janssen-Cilag International NV
- Condition
- Schizophrenia
CompletedNCT02713282
This study exists to explore whether the medication Transition could improve care and understanding. Researchers are trying to understand whether the medication Transition can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- Croatia, Denmark, France, Germany, Greece, Israel, Malaysia, Netherlands, Russian Federation, Saudi Arabia, South Korea, Spain, Taiwan, Turkey, United Kingdom
- Sponsor
- Janssen-Cilag Ltd.
- Condition
- Schizophrenia
CompletedNCT03809325
This study exists to explore whether questionnaires and follow-up reports could improve care and understanding. Researchers are trying to understand what questionnaires and follow-up reports could change in day-to-day care and decision-making.
SchizophreniaOtherOver 18 Years
- Countries
- Belgium, France, Germany, Hungary, Italy, Spain, United Kingdom
- Sponsor
- Janssen-Cilag International NV
- Condition
- Schizophrenia
RecruitingNCT06224530
This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 40 Years
- Countries
- United Kingdom
- Sponsor
- King's College London
- Condition
- Schizophrenia
CompletedNCT04038957
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 45 Years
- Countries
- United Kingdom
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
RecruitingNCT05127278
This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 12 Years to 35 Years
- Countries
- United Kingdom
- Sponsor
- King's College London
- Condition
- Schizophrenia
RecruitingNCT06703827
This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can play a useful role in care. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United Kingdom
- Sponsor
- City, University of London
- Condition
- Schizophrenia
CompletedNCT05670197
This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can better prevent setbacks and support longer-term stability.
SchizophreniaOtherOver 16 Years
- Countries
- United Kingdom
- Sponsor
- Manchester Academic Health Science Centre
- Condition
- Schizophrenia
CompletedNCT01972711
This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.
SchizophreniaOtherFrom 18 Years to 45 Years
- Countries
- United Kingdom
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
CompletedNCT03093064
This study exists to learn from real-world information that can show how brain scans or other body measurements fits into care. Researchers are trying to understand what brain scans or other body measurements can reveal about signals in the brain or body that may guide care later on.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- United Kingdom
- Sponsor
- King's College London
- Condition
- Schizophrenia
CompletedNCT05281640
This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United Kingdom
- Sponsor
- Edinburgh Napier University
- Condition
- Schizophrenia
CompletedNCT06190483
This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 40 Years
- Countries
- United Kingdom
- Sponsor
- King's College London
- Condition
- Schizophrenia
CompletedNCT03859973
This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand what a medication treatment can reveal about signals in the brain or body that may guide care later on.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- Australia, Canada, France, New Zealand, United Kingdom, United States
- Sponsor
- Boehringer Ingelheim
- Condition
- Schizophrenia
CompletedNCT05633108
This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can better prevent setbacks and support longer-term stability.
SchizophreniaOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- Eisai Co., Ltd.
- Condition
- Schizophrenia
CompletedNCT04605393
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United Kingdom
- Sponsor
- King's College London
- Condition
- Schizophrenia
CompletedNCT04180709
This study exists to understand how cognitive behavioural therapy, a structured talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- University of Cambridge
- Condition
- Schizophrenia
CompletedNCT05377294
This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.
SchizophreniaOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- University of Manchester
- Condition
- Schizophrenia
CompletedNCT03114917
This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- University of Manchester
- Condition
- Schizophrenia